Related Experiment Videos
Reninlike enzymes in human vasculature
J Rosenthal1, M Thurnreiter, M Plaschke
1Ulm University Medical Center, FRG.
Hypertension (Dallas, Tex. : 1979)
|June 1, 1990
Summary
This study identified three nonrenin angiotensin I-forming angiotensinogenases in human vasculature and heart tissue. Essential hypertension did not show general stimulation of these enzymes, challenging previous theories.
Area of Science:
- Biochemistry
- Cardiovascular Physiology
- Hypertension Research
Background:
- Angiotensin I (Ang I)-forming enzymes are crucial in the renin-angiotensin system.
- Previous theories suggested stimulation of these enzymes in essential hypertension.
- Understanding extrarenal sources of Ang I is vital for cardiovascular health.
Purpose of the Study:
- To identify Ang I-forming angiotensinogenases in human extrarenal vasculature.
- To investigate the theory of Jiménez Días regarding their stimulation in essential hypertension.
- To characterize the activity and distribution of these enzymes.
Main Methods:
- Enzyme-kinetic assays using Ang I radioimmunoassay and purified angiotensinogens.
- Analysis of vascular sections from normotensive and hypertensive patients, umbilical cords, explanted hearts, and serum.
- Determination of pH optima for identified enzymes.
Main Results:
- Three nonrenin Ang I-forming angiotensinogenases with distinct pH optima were identified in extrarenal vasculature, cardiac tissue, and plasma.
- Highest activities were observed in cardiac tissue, followed by carotid artery intima and other arteries.
- Extrarenal arterial enzyme activities showed linear correlation with local angiotensin-converting enzyme and plasma renin activity.
- Essential hypertension did not exhibit general stimulation of these enzymes.
Conclusions:
- Nonrenin Ang I-forming angiotensinogenases exist in human extrarenal vasculature, kidney, and plasma.
- The theory of stimulated extrarenal arterial Ang I-forming angiotensinogenases in essential hypertension is not supported by this data.
- A classification system for Ang I-forming angiotensinogenase activity in hypertension is proposed, categorizing patients into high, normal, or low activity subgroups.